Literature DB >> 32052251

Co-occurrence of multiple endocrine neoplasia type 4 and spinal neurofibromatosis: a case report.

Pamela Brock1, Jean Bustamante Alvarez2, Amir Mortazavi2, Sameek Roychowdhury2, John Phay3, Raheela A Khawaja4, Manisha H Shah2, Bhavana Konda5.   

Abstract

Multiple Endocrine Neoplasia (MEN) type 4 is a rare genetic condition that results from variants of the CDKN1B gene and predisposes individuals to develop endocrine tumors. Spinal neurofibromatosis (SNF) is an uncommon subtype of neurofibromatosis type 1 (NF1) characterized by bilateral neurofibromas of all spinal roots. Here we report a case of the co-occurrence of these syndromes, which has not yet been described in the literature. A male in his 60s presented with Gleason 5 + 4 localized prostate adenocarcinoma treated with radical prostatectomy. Two years later, he developed liver and bone metastasis consistent with trans-differentiation into small cell carcinoma. He developed hypercalcemia due to primary hyperparathyroidism from a parathyroid adenoma treated surgically. His family history was significant for a first-degree relative with a clinical diagnosis of NF1 and several second-degree relatives with multiple café-au-lait macules. Spine MRI showed multiple bilateral neurofibromas. Germline genetic testing showed a pathogenic variant in the CDKN1B gene, a variant in the NF1 gene, and a normal MEN1 gene. In this rare case of MEN4 and SNF, the patient was asymptomatic for much of his life. In addition to parathyroid adenoma and spinal neurofibromas, he had prostate adenocarcinoma with trans-differentiation into metastatic small cell cancer. Whether this diagnosis was coincidental or related to an emerging phenotype remains to be elucidated.

Entities:  

Keywords:  Molecular genetics; Multiple endocrine neoplasia; Neuroendocrine tumors; Parathyroid

Mesh:

Substances:

Year:  2020        PMID: 32052251     DOI: 10.1007/s10689-019-00152-6

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  11 in total

Review 1.  MEN4 and CDKN1B mutations: the latest of the MEN syndromes.

Authors:  Rami Alrezk; Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2017-08-19       Impact factor: 5.678

2.  Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.

Authors:  I Lemmens; W J Van de Ven; K Kas; C X Zhang; S Giraud; V Wautot; N Buisson; K De Witte; J Salandre; G Lenoir; M Pugeat; A Calender; F Parente; D Quincey; P Gaudray; M J De Wit; C J Lips; J W Höppener; S Khodaei; A L Grant; G Weber; S Kytölä; B T Teh; F Farnebo; R V Thakker
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

3.  Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.

Authors:  S K Agarwal; M B Kester; L V Debelenko; C Heppner; M R Emmert-Buck; M C Skarulis; J L Doppman; Y S Kim; I A Lubensky; Z Zhuang; J S Green; S C Guru; P Manickam; S E Olufemi; L A Liotta; S C Chandrasekharappa; F S Collins; A M Spiegel; A L Burns; S J Marx
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

4.  Association between atypical parathyroid adenoma and neurofibromatosis.

Authors:  Aline Mesquita Ferreira de Favere; Daniela Miti Tsukumo; Patrícia Sabino de Matos; Sérgio Luiz Marques dos Santos; Cristina Alba Lalli
Journal:  Arch Endocrinol Metab       Date:  2015-09-25       Impact factor: 2.309

5.  Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.

Authors:  Natalia S Pellegata; Leticia Quintanilla-Martinez; Heide Siggelkow; Elenore Samson; Karin Bink; Heinz Höfler; Falko Fend; Jochen Graw; Michael J Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

Review 6.  von Recklinghausen's disease and pheochromocytomas.

Authors:  M M Walther; J Herring; E Enquist; H R Keiser; W M Linehan
Journal:  J Urol       Date:  1999-11       Impact factor: 7.450

7.  Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing.

Authors:  S Ellard; A T Hattersley; C M Brewer; B Vaidya
Journal:  Clin Endocrinol (Oxf)       Date:  2005-02       Impact factor: 3.478

Review 8.  The natural history of spinal neurofibromatosis: a critical review of clinical and genetic features.

Authors:  M Ruggieri; A Polizzi; A Spalice; V Salpietro; R Caltabiano; V D'Orazi; P Pavone; C Pirrone; G Magro; N Platania; S Cavallaro; M Muglia; F Nicita
Journal:  Clin Genet       Date:  2014-11-22       Impact factor: 4.438

9.  Familial spinal neurofibromatosis: clinical and DNA linkage analysis.

Authors:  S M Pulst; V M Riccardi; P Fain; J R Korenberg
Journal:  Neurology       Date:  1991-12       Impact factor: 9.910

10.  Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.

Authors:  Giovanni Corsello; Vincenzo Antona; Gregorio Serra; Federico Zara; Clara Giambrone; Luca Lagalla; Maria Piccione; Ettore Piro
Journal:  Ital J Pediatr       Date:  2018-04-04       Impact factor: 2.638

View more
  2 in total

Review 1.  Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management.

Authors:  Elisabetta Lavezzi; Alessandro Brunetti; Valeria Smiroldo; Gennaro Nappo; Vittorio Pedicini; Eleonora Vitali; Giampaolo Trivellin; Gherardo Mazziotti; Andrea Lania
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-09       Impact factor: 5.555

2.  MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations.

Authors:  Amanda Seabrook; Ayanthi Wijewardene; Sunita De Sousa; Tang Wong; Nisa Sheriff; Anthony J Gill; Rakesh Iyer; Michael Field; Catherine Luxford; Roderick Clifton-Bligh; Ann McCormack; Katherine Tucker
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.